Gain Therapeutics Revenue vs. Number Of Shares Shorted

GANX Stock  USD 1.86  0.12  6.90%   
Based on Gain Therapeutics' profitability indicators, Gain Therapeutics may not be well positioned to generate adequate gross income at this time. It has a very high odds of underperforming in December. Profitability indicators assess Gain Therapeutics' ability to earn profits and add value for shareholders.
 
Total Revenue  
First Reported
2017-12-31
Previous Quarter
0.0
Current Value
0.0
Quarterly Volatility
36.1 K
 
Covid
At this time, Gain Therapeutics' Days Sales Outstanding is fairly stable compared to the past year. Sales General And Administrative To Revenue is likely to rise to 205.28 in 2024, whereas Price To Sales Ratio is likely to drop 732.51 in 2024. At this time, Gain Therapeutics' Accumulated Other Comprehensive Income is fairly stable compared to the past year. Net Interest Income is likely to rise to about 579.3 K in 2024, despite the fact that Operating Income is likely to grow to (21.1 M).
For Gain Therapeutics profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Gain Therapeutics to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Gain Therapeutics utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Gain Therapeutics's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Gain Therapeutics over time as well as its relative position and ranking within its peers.
  
Check out Risk vs Return Analysis.
For more information on how to buy Gain Stock please use our How to Invest in Gain Therapeutics guide.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Gain Therapeutics. If investors know Gain will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Gain Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.07)
Quarterly Revenue Growth
(1.00)
Return On Assets
(0.73)
Return On Equity
(1.89)
The market value of Gain Therapeutics is measured differently than its book value, which is the value of Gain that is recorded on the company's balance sheet. Investors also form their own opinion of Gain Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Gain Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Gain Therapeutics' market value can be influenced by many factors that don't directly affect Gain Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Gain Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Gain Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Gain Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Gain Therapeutics Number Of Shares Shorted vs. Revenue Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Gain Therapeutics's current stock value. Our valuation model uses many indicators to compare Gain Therapeutics value to that of its competitors to determine the firm's financial worth.
Gain Therapeutics is rated # 4 in revenue category among its peers. It also is rated # 4 in number of shares shorted category among its peers making about  13.03  of Number Of Shares Shorted per Revenue. At this time, Gain Therapeutics' Total Revenue is fairly stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Gain Therapeutics' earnings, one of the primary drivers of an investment's value.

Gain Revenue vs. Competition

Gain Therapeutics is rated # 4 in revenue category among its peers. Market size based on revenue of Health Care industry is currently estimated at about 9.63 Million. Gain Therapeutics maintains roughly 55,180 in revenue contributing less than 1% to equities under Health Care industry.

Gain Number Of Shares Shorted vs. Revenue

Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.

Gain Therapeutics

Revenue

 = 

Money Received

-

Discounts and Returns

 = 
55.18 K
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Number of Shares Shorted is the total amount of shares that are currently sold short by investors. When a stock is sold short, the short seller assumes the responsibility of repurchasing the stock at a lower price. The speculator will make money if the stock goes down in price or will experience a loss if the stock price goes up.

Gain Therapeutics

Shares Shorted

 = 

Shorted by Public

+

by Institutions

 = 
718.74 K
If a large number of investors decide to short sell an equity instrument within a small period of time, their combined action can significantly affect the price of the stock.

Gain Number Of Shares Shorted Comparison

Gain Therapeutics is currently under evaluation in number of shares shorted category among its peers.

Gain Therapeutics Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Gain Therapeutics, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Gain Therapeutics will eventually generate negative long term returns. The profitability progress is the general direction of Gain Therapeutics' change in net profit over the period of time. It can combine multiple indicators of Gain Therapeutics, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Accumulated Other Comprehensive Income247.2 K259.6 K
Net Interest Income551.7 K579.3 K
Operating Income-22.3 M-21.1 M
Net Loss-22.2 M-21.1 M
Income Before Tax-22.2 M-21.1 M
Total Other Income Expense Net64.9 K68.1 K
Net Loss-15.8 M-15 M
Net Loss-22.3 M-21.2 M
Income Tax Expense79.3 K83.2 K
Interest Income494.2 K478.3 K
Non Operating Income Net Other-86.5 K-90.8 K
Change To Netincome1.5 M1.6 M
Net Loss(1.71)(1.80)
Income Quality 0.85  0.66 
Net Income Per E B T 1.00  1.10 

Gain Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Gain Therapeutics. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Gain Therapeutics position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Gain Therapeutics' important profitability drivers and their relationship over time.

Use Gain Therapeutics in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Gain Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Gain Therapeutics will appreciate offsetting losses from the drop in the long position's value.

Gain Therapeutics Pair Trading

Gain Therapeutics Pair Trading Analysis

The ability to find closely correlated positions to Gain Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Gain Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Gain Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Gain Therapeutics to buy it.
The correlation of Gain Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Gain Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Gain Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Gain Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Gain Therapeutics position

In addition to having Gain Therapeutics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Blockchain Thematic Idea Now

Blockchain
Blockchain Theme
Companies across muliple sectors and different technology products and services that are engaged in some capacity with blockchain technolgoy or evolution of cryptocurrency. The Blockchain theme has 42 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Blockchain Theme or any other thematic opportunities.
View All  Next Launch

Additional Tools for Gain Stock Analysis

When running Gain Therapeutics' price analysis, check to measure Gain Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Gain Therapeutics is operating at the current time. Most of Gain Therapeutics' value examination focuses on studying past and present price action to predict the probability of Gain Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Gain Therapeutics' price. Additionally, you may evaluate how the addition of Gain Therapeutics to your portfolios can decrease your overall portfolio volatility.